Curis (CRIS) Change in Acquisitions & Divestments (2010 - 2024)
Curis' (CRIS) quarterly Change in Acquisitions & Divestments came in at -$428000.0 in Q4 2024, down 102.12% YoY from $20.2 million in Q1 2024, and down 102.34% on a QoQ basis from $18.3 million in Q3 2024.
Curis (CRIS) Change in Acquisitions & Divestments (2010 - 2024) Analysis & Trends
Curis (CRIS) has 15 years of Change in Acquisitions & Divestments data on file, last reported at -$428000.0 in Q4 2024.
- Quarterly Change in Acquisitions & Divestments fell 102.12% year-over-year to -$428000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$428000.0 (down 100.63% YoY) and the FY2024 annual result came in at $47.5 million, down 56.03% from the prior year.
- Change in Acquisitions & Divestments eased to -$428000.0 in Q4 2024, from $18.3 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $43.9 million in Q1 2023 to a low of -$428000.0 in Q4 2024.
- A 5-year average of $17.7 million and a median of $18.0 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments surged 112600.0% — and 2024, when it tumbled 102.12%.
- Tracing CRIS's Change in Acquisitions & Divestments over 5 years: stood at -$4000.0 in 2020, then jumped by 465725.0% to $18.6 million in 2021, then slipped by 13.86% to $16.0 million in 2022, then gained by 25.91% to $20.2 million in 2023, then plunged by 102.12% to -$428000.0 in 2024.
- The last three Change in Acquisitions & Divestments figures came in at -$428000.0 (Q4 2024), $18.3 million (Q3 2024), and $29.6 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -428,000.00 |
| Dec 31, 2024 | -428,000.00 |
| Sep 30, 2024 | 18.32 Mn |
| Sep 30, 2024 | 18.32 Mn |
| Mar 31, 2024 | 29.65 Mn |
| Mar 31, 2024 | 29.65 Mn |
| Dec 31, 2023 | 20.20 Mn |
| Dec 31, 2023 | 20.20 Mn |
| Sep 30, 2023 | 36.50 Mn |
| Sep 30, 2023 | 36.50 Mn |
| Jun 30, 2023 | 7.50 Mn |
| Jun 30, 2023 | 7.50 Mn |
| Mar 31, 2023 | 43.93 Mn |
| Mar 31, 2023 | 43.93 Mn |
| Dec 31, 2022 | 16.04 Mn |
| Dec 31, 2022 | 16.04 Mn |
| Sep 30, 2022 | 18.00 Mn |
| Sep 30, 2022 | 18.00 Mn |
| Jun 30, 2022 | 39.50 Mn |
| Jun 30, 2022 | 39.50 Mn |